10/23/2026
October is ADHD Awareness Month, a time to shift the narrative from struggle to support.
At Alcanza Clinical Research, we recognize that lived experiences drive meaningful science. Millions of adults and children navigate the daily realities of ADHD, and behind every protocol we work, our priority remains clear: putting patients and their families at the center of innovation.
Through human-centered clinical trials, we are dedicated to advancing safe, effective, and accessible options that improve everyday life and long-term outcomes.
Together, let’s continue building a world where neurodiversity is supported, understood, and empowered. 🌐💡